SMARCB1-deficient sinonasal carcinomas constitute 4.7% of sinonasal carcinomas in our cohort; and none were SMARCA4-deficient carcinomas. This evidence concerns the gene SMARCA4 and nasal cavity and paranasal sinus carcinoma.